{"title":"Application of autologous succus entericus reinfusion after enterostomy in neonate","authors":"Yajuan Xu, Ping Yan, Yanbo Wang, Wen-Chun Sun, Weibing Tang","doi":"10.3760/CMA.J.ISSN.1674-635X.2019.02.011","DOIUrl":null,"url":null,"abstract":"Objective \nTo evaluate the application way and value of autologous succus entericus reinfusion in neonatal enterostomy. \n \n \nMethods \nClinical data from 109 neonatal patients receiving enterostomy in Children's Hospital of Nanjing Medical University from January 2010 to December 2017 were retrospectively analyzed. The neonatal patients were divided into two groups according to whether succus entericus reinfusion conducted as succus entericus reinfusion group (63 neonatal patients) and control group (46 neonatal patients). The 90-day weight gain of the neonatal patients, age of the second stage enterostomy closure, cessation of intravenous infusion time after operation and the rate of re-admission before the second stage enterostomy closure were collected. \n \n \nResults \nThe distance between enterostomy mouth and the Treitz ligament was 80-120 cm in all the children patients, and there was no significant difference between the two groups (P=0.42). The succus entericus reinfusion group was superior to the control group in the weight gain of 90 days after birth (single lumen group vs. single lumen control group: [1.97±0.55] vs. [1.50±0.57]kg, P=0.017; double lumens group vs. double lumens control group: [1.82±0.49]vs. [1.48±0.65] kg, P=0.013), age of the second stage enterostomy closure (single lumen group vs. single lumen control group: [115.76±15.85] vs. [117.40±11.06] d, P=0.025; double lumens group vs. double lumens control group: [115.48±14.33] vs. [126.03±8.85] d, P=0.001), cessation of intravenous infusion time after operation (single lumen group vs. single lumen control group: [ 14.24±3.30] vs. [16.40±2.74] d, P=0.046; double lumens group vs. double lumens control group: [15.07±3.65] vs. [18.71±3.63] d, P<0.01), and the rate of re-admission before the second stage enterostomy closure (single lumen group vs. single lumen control group: 9.5%[2/21]vs. 20%[3/15], P=0.337; double lumens group vs. double lumens control group: 7.1%[3/42]vs. 25.8%[8/31], P=0.028). \n \n \nConclusion \nAutologous succus entericus reinfusion can improve the absorption of nutrients after the operation of small intestinal stoma, improve the function of the distal enteral tube, and create conditions for the early recovery of intestinal continuity. \n \n \nKey words: \nNeonate; Small intestine stoma; Succus entericus reinfusion","PeriodicalId":9877,"journal":{"name":"中华临床营养杂志","volume":"27 1","pages":"123-128"},"PeriodicalIF":0.0000,"publicationDate":"2019-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华临床营养杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2019.02.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To evaluate the application way and value of autologous succus entericus reinfusion in neonatal enterostomy.
Methods
Clinical data from 109 neonatal patients receiving enterostomy in Children's Hospital of Nanjing Medical University from January 2010 to December 2017 were retrospectively analyzed. The neonatal patients were divided into two groups according to whether succus entericus reinfusion conducted as succus entericus reinfusion group (63 neonatal patients) and control group (46 neonatal patients). The 90-day weight gain of the neonatal patients, age of the second stage enterostomy closure, cessation of intravenous infusion time after operation and the rate of re-admission before the second stage enterostomy closure were collected.
Results
The distance between enterostomy mouth and the Treitz ligament was 80-120 cm in all the children patients, and there was no significant difference between the two groups (P=0.42). The succus entericus reinfusion group was superior to the control group in the weight gain of 90 days after birth (single lumen group vs. single lumen control group: [1.97±0.55] vs. [1.50±0.57]kg, P=0.017; double lumens group vs. double lumens control group: [1.82±0.49]vs. [1.48±0.65] kg, P=0.013), age of the second stage enterostomy closure (single lumen group vs. single lumen control group: [115.76±15.85] vs. [117.40±11.06] d, P=0.025; double lumens group vs. double lumens control group: [115.48±14.33] vs. [126.03±8.85] d, P=0.001), cessation of intravenous infusion time after operation (single lumen group vs. single lumen control group: [ 14.24±3.30] vs. [16.40±2.74] d, P=0.046; double lumens group vs. double lumens control group: [15.07±3.65] vs. [18.71±3.63] d, P<0.01), and the rate of re-admission before the second stage enterostomy closure (single lumen group vs. single lumen control group: 9.5%[2/21]vs. 20%[3/15], P=0.337; double lumens group vs. double lumens control group: 7.1%[3/42]vs. 25.8%[8/31], P=0.028).
Conclusion
Autologous succus entericus reinfusion can improve the absorption of nutrients after the operation of small intestinal stoma, improve the function of the distal enteral tube, and create conditions for the early recovery of intestinal continuity.
Key words:
Neonate; Small intestine stoma; Succus entericus reinfusion
期刊介绍:
The Chinese Journal of Clinical Nutrition was founded in 1993. It is the first professional academic journal (bimonthly) in my country co-sponsored by the Chinese Medical Association and the Chinese Academy of Medical Sciences to disseminate information on clinical nutrition support, nutrient metabolism, the impact of nutrition support on outcomes and "cost-effectiveness", as well as translational medicine and nutrition research. It is also a professional journal of the Chinese Medical Association's Parenteral and Enteral Nutrition Branch.
The purpose of the Chinese Journal of Clinical Nutrition is to promote the rapid dissemination of knowledge on nutrient metabolism and the rational application of parenteral and enteral nutrition, focusing on the combination of multidisciplinary and multi-regional field investigations and clinical research. It mainly reports on nutritional risk screening related to the indications of parenteral and enteral nutrition support, "cost-effectiveness" research on nutritional drugs, consensus on clinical nutrition, guidelines, expert reviews, randomized controlled studies, cohort studies, glycoprotein and other nutrient metabolism research, systematic evaluation of clinical research, evidence-based case reports, special reviews, case reports and clinical experience exchanges, etc., and has a special column on new technologies related to the field of clinical nutrition and their clinical applications.